Maryland House Passes Right to Try Act to Reject Some FDA Restrictions on Terminal Patients
ANNAPOLIS, Md. (March 21, 2017) – Yesterday, the Maryland House unanimously passed a bill that would set the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients. Introduced by Del. Karen Young (D-Frederick) and 18 bipartisan co-sponsors, House Bill 584 (HB584) would…